The Medicines Company is looking for highly talented and motivated leaders to drive our growth and expand our leadership in acute care medicine worldwide.

We recently took our first step directly into international markets by re-acquiring rights to our flagship product, Angiomax/Angiox, in Europe. We are also expanding our portfolio of innovative and cost-effective acute care products, with two highly promising products in registration or late-stage development.

We invite qualified candidates to learn more about our vision, our plans for growth, and career opportunities. See for yourself!